PMID- 29238034 OWN - NLM STAT- MEDLINE DCOM- 20180806 LR - 20221207 IS - 1643-3750 (Electronic) IS - 1234-1010 (Print) IS - 1234-1010 (Linking) VI - 23 DP - 2017 Dec 14 TI - Inverse Relationship Between Serum Bilirubin Levels and Diabetic Foot in Chinese Patients with Type 2 Diabetes Mellitus. PG - 5916-5923 AB - BACKGROUND Several studies demonstrated that bilirubin, a potent endogenous antioxidant, is a strong protective factor for many diabetic complications such as nephropathy, retinopathy, neuropathy, and vasculopathy. The purpose of this study was to assess the association between serum bilirubin levels and diabetic foot (DF) in Chinese patients with type 2 diabetes mellitus (T2DM). MATERIAL AND METHODS The present cross-sectional study of bilirubin levels in relation to DF was conducted in 1,269 T2DM patients with (n=578) and without (n=691) DF. Blood test results were obtained on hospital admission, including total bilirubin (T-BIL), direct bilirubin (D-BIL), and indirect bilirubin (I-BIL). Data on Wagner classification and amputation procedure in patients with DF were collected by reviewing electronic medical records. Univariate or multivariate analysis were performed to explore the association between bilirubin and DF. RESULTS Serum I-BIL levels were shown to play a protective role regarding the presence and severity of DF (OR=0.75, p=0.029 and OR=0.90, p=0.021, respectively). In addition, in a comparison of the lowest and highest tertiles of serum bilirubin concentration, the highest tertile of serum T-BIL (OR=0.51, p=0.011) and I-BIL (OR=0.28, p<0.001) was significantly related with a lower Wagner grade of DF. Patients with DF in the highest tertiles of T-BIL carried a significantly lower risk of amputation events than those in the lowest tertiles (OR=0.47, p=0.025). CONCLUSIONS The present study provided evidence that decreased serum bilirubin levels were independently associated with the presence and severity of DF and amputation events in patients with DF. FAU - Chen, Jifan AU - Chen J AD - School of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China (mainland). FAU - Wang, Jian AU - Wang J AD - School of the First Clinical Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China (mainland). FAU - Zhang, Xingxing AU - Zhang X AD - Department of Endocrinology and Metabolism, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China (mainland). FAU - Zhu, Hong AU - Zhu H AD - Department of Endocrinology and Metabolism, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China (mainland). LA - eng PT - Journal Article DEP - 20171214 PL - United States TA - Med Sci Monit JT - Medical science monitor : international medical journal of experimental and clinical research JID - 9609063 RN - RFM9X3LJ49 (Bilirubin) SB - IM MH - Aged MH - Asian People MH - Bilirubin/*analysis/blood MH - China MH - Cross-Sectional Studies MH - Diabetes Mellitus, Type 2/blood/complications MH - Diabetic Foot/blood/*metabolism MH - Female MH - Humans MH - Male MH - Middle Aged MH - Risk Factors PMC - PMC5739530 COIS- Conflict of interests None. EDAT- 2017/12/15 06:00 MHDA- 2018/08/07 06:00 PMCR- 2017/12/14 CRDT- 2017/12/15 06:00 PHST- 2017/12/15 06:00 [entrez] PHST- 2017/12/15 06:00 [pubmed] PHST- 2018/08/07 06:00 [medline] PHST- 2017/12/14 00:00 [pmc-release] AID - 907248 [pii] AID - 10.12659/msm.907248 [doi] PST - epublish SO - Med Sci Monit. 2017 Dec 14;23:5916-5923. doi: 10.12659/msm.907248.